Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 6 | 2023 | 1329 | 1.260 |
Why?
|
| Pancreatic Neoplasms | 6 | 2023 | 5256 | 0.600 |
Why?
|
| Fiducial Markers | 1 | 2015 | 136 | 0.460 |
Why?
|
| Adenocarcinoma | 4 | 2023 | 6364 | 0.400 |
Why?
|
| Endosonography | 1 | 2015 | 610 | 0.380 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 11124 | 0.330 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2008 | 71 | 0.310 |
Why?
|
| Indans | 1 | 2008 | 96 | 0.300 |
Why?
|
| Brachytherapy | 1 | 2015 | 1248 | 0.290 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2008 | 238 | 0.280 |
Why?
|
| Rectal Neoplasms | 1 | 2015 | 1206 | 0.260 |
Why?
|
| Troponin | 1 | 2009 | 524 | 0.260 |
Why?
|
| Prostate-Specific Antigen | 2 | 2024 | 2494 | 0.230 |
Why?
|
| Urogenital System | 1 | 2023 | 86 | 0.230 |
Why?
|
| Cancer Care Facilities | 2 | 2015 | 402 | 0.210 |
Why?
|
| Benzodiazepines | 1 | 2008 | 1101 | 0.200 |
Why?
|
| Piperidines | 1 | 2008 | 1602 | 0.170 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15540 | 0.140 |
Why?
|
| Refugees | 1 | 2023 | 511 | 0.140 |
Why?
|
| Prostate | 1 | 2023 | 1774 | 0.130 |
Why?
|
| Sepsis | 1 | 2009 | 2593 | 0.130 |
Why?
|
| Natural Language Processing | 1 | 2023 | 1041 | 0.130 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2020 | 1770 | 0.120 |
Why?
|
| Lymphopenia | 1 | 2015 | 285 | 0.110 |
Why?
|
| Quality of Life | 1 | 2015 | 12804 | 0.110 |
Why?
|
| Neoplasm Staging | 3 | 2024 | 11031 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1634 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 281 | 0.090 |
Why?
|
| Male | 15 | 2024 | 350118 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 950 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 2 | 2020 | 2728 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2013 | 790 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4215 | 0.080 |
Why?
|
| Retrospective Studies | 7 | 2024 | 77449 | 0.070 |
Why?
|
| Aged | 7 | 2023 | 163280 | 0.070 |
Why?
|
| Troponin I | 1 | 2009 | 619 | 0.060 |
Why?
|
| Humans | 17 | 2024 | 744343 | 0.060 |
Why?
|
| Iraq | 1 | 2024 | 92 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7913 | 0.060 |
Why?
|
| Self Report | 1 | 2015 | 3558 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2015 | 2531 | 0.060 |
Why?
|
| Lebanon | 1 | 2024 | 229 | 0.060 |
Why?
|
| Syria | 1 | 2023 | 76 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39050 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2009 | 775 | 0.050 |
Why?
|
| Neoplasms | 2 | 2023 | 21683 | 0.050 |
Why?
|
| Middle Aged | 6 | 2015 | 213383 | 0.050 |
Why?
|
| Female | 10 | 2023 | 380194 | 0.050 |
Why?
|
| Survival Rate | 1 | 2015 | 12788 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57776 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2020 | 876 | 0.040 |
Why?
|
| Hypertension | 2 | 2009 | 8480 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2023 | 53288 | 0.040 |
Why?
|
| Social Environment | 1 | 2023 | 1023 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 2046 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2023 | 1915 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2020 | 1005 | 0.040 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2020 | 503 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2007 | 2266 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
| Probability | 1 | 2020 | 2505 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2023 | 1624 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 1377 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29063 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 25043 | 0.030 |
Why?
|
| Medical Audit | 1 | 2015 | 467 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 793 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5078 | 0.030 |
Why?
|
| Baltimore | 1 | 2013 | 231 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 40561 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 640 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2015 | 826 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2015 | 574 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2015 | 1619 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 214055 | 0.020 |
Why?
|
| Linear Models | 1 | 2020 | 5952 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2214 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 7279 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.020 |
Why?
|
| Data Mining | 1 | 2015 | 537 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2023 | 12026 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 6487 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2020 | 3589 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 11727 | 0.020 |
Why?
|
| Health Services Research | 1 | 2015 | 1836 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2013 | 2879 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10397 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2013 | 1180 | 0.020 |
Why?
|
| Models, Biological | 1 | 2020 | 9583 | 0.010 |
Why?
|
| Research Design | 1 | 2020 | 5987 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2013 | 6459 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11524 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2007 | 733 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2007 | 1179 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6895 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2007 | 2071 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 3966 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 10388 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 8554 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 41006 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 56430 | 0.000 |
Why?
|
| Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 85781 | 0.000 |
Why?
|
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_